Ontology highlight
ABSTRACT: Objective
Pharmacokinetic variability drives tuberculosis (TB) treatment outcomes but measurement of serum drug concentrations for personalised dosing is inaccessible for children in TB-endemic settings. We compared rifampin urine excretion for prediction of a serum target associated with treatment outcome.Design
Prospective diagnostic accuracy study.Setting
Inpatient wards and outpatient clinics, northern Tanzania.Patients
Children aged 4-17 years were consecutively recruited on initiation of WHO-approved treatment regimens.Interventions
Samples were collected after directly observed therapy at least 2 weeks after initiation in the intensive phase: serum at pre-dose and 1, 2 and 6 hours post-dose, later analysed by liquid chromatography-tandem mass spectrometry for calculation of rifampin total exposure or area under the concentration time curve (AUC0-24); urine at post-dose intervals of 0-4, 4-8 and 8-24 hours, with rifampin excretion amount measured onsite by spectrophotometry.Main outcome measures
Receiver operating characteristic (ROC) curve for percentage of rifampin dose excreted in urine measured by spectrophotometry to predict serum rifampin AUC0-24 target of 31.7 mg*hour/L.Results
89 children, 52 (58%) female, with median age of 9.1 years, had both serum and urine collection. Only 59 (66%) reached the serum AUC0-24 target, reflected by a range of urine excretion patterns. Area under the ROC curve for percentage of rifampin dose excreted in urine over 24 hours predicting serum AUC0-24 target was 69.3% (95% CI 56.7% to 81.8%), p=0.007.Conclusions
Urine spectrophotometry correlated with a clinically relevant serum target for rifampin, representing a step toward personalised dosing for children in TB-endemic settings.
SUBMITTER: Thomas TA
PROVIDER: S-EPMC10766442 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature
Thomas Tania A TA Lukumay Saning'o S Yu Sijia S Rao Prakruti P Siemiątkowska Anna A Kagan Leonid L Augustino Domitila D Mejan Paulo P Mosha Restituta R Handler Deborah D Petros de Guex Kristen K Mmbaga Blandina B Pfaeffle Herman H Reiss Robert R Peloquin Charles A CA Vinnard Christopher C Mduma Estomih E Xie Yingda L YL Heysell Scott K SK
Archives of disease in childhood 20230425 8
<h4>Objective</h4>Pharmacokinetic variability drives tuberculosis (TB) treatment outcomes but measurement of serum drug concentrations for personalised dosing is inaccessible for children in TB-endemic settings. We compared rifampin urine excretion for prediction of a serum target associated with treatment outcome.<h4>Design</h4>Prospective diagnostic accuracy study.<h4>Setting</h4>Inpatient wards and outpatient clinics, northern Tanzania.<h4>Patients</h4>Children aged 4-17 years were consecutiv ...[more]